247
Participants
Start Date
December 31, 2012
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
Botulinum Toxin Type A
Botulinum Toxin Type A, Dose A; dose applied to the lateral canthal lines
Placebo
Placebo, Dose B; dose applied to the lateral canthal lines
Dermatology Research Institute, Coral Gables
Revance Therapeutics, Inc.
INDUSTRY